How to Reconstitute IGF-1 LR3: Step-by-Step Laboratory Protocol

IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) represents a synthetic analog of naturally occurring IGF-1, engineered with enhanced stability and extended half-life characteristics. This modified peptide contains 83 amino acids and exhibits reduced binding affinity to IGF binding proteins, making it particularly valuable for in vitro cellular research applications. Laboratory investigations commonly utilize IGF-1 LR3 to examine cellular proliferation mechanisms, metabolic pathway modulation, and protein synthesis regulation in various cell culture systems.

Required Laboratory Materials

  • IGF-1 LR3 lyophilized powder (1mg vial)
  • Bacteriostatic water for injection or sterile water for injection
  • Sterile low-protein-binding microcentrifuge tubes
  • Calibrated micropipettes (10-1000μL range)
  • Sterile pipette tips with aerosol barrier
  • Laminar flow hood or biological safety cabinet
  • 70% isopropyl alcohol for surface sterilization
  • Sterile gauze pads
  • Laboratory-grade analytical balance
  • Vortex mixer (optional)
  • Refrigerated storage unit (-20°C to +4°C)

Pre-Reconstitution Preparation Protocol

Establish sterile working conditions within a laminar flow hood, ensuring all surfaces undergo thorough decontamination with 70% isopropyl alcohol. Allow the lyophilized IGF-1 LR3 vial to equilibrate to room temperature for approximately 15-20 minutes before initiating reconstitution procedures. This temperature equilibration prevents thermal shock to the peptide structure and reduces condensation formation during solvent addition.

Verify the integrity of all materials and confirm expiration dates on sterile water supplies. Inspect the lyophilized powder for uniform appearance and absence of discoloration, which should present as a white to off-white crystalline material. Calculate the required solvent volume based on desired final concentration using the formula: Volume (mL) = Mass (mg) ÷ Desired Concentration (mg/mL).

Step-by-Step Reconstitution Procedure

Step 1: Remove the plastic cap from the IGF-1 LR3 vial and sterilize the rubber stopper using alcohol-soaked gauze. Allow the alcohol to evaporate completely before proceeding to prevent chemical interference with the peptide.

Step 2: Using a calibrated micropipette, slowly draw the calculated volume of bacteriostatic water or sterile water into a sterile pipette tip. Ensure precise volume measurement for accurate concentration determination.

Step 3: Insert the pipette tip through the rubber stopper at a slight angle to minimize coring. Direct the solvent stream toward the vial wall rather than directly onto the lyophilized powder to prevent foaming and potential peptide degradation.

Step 4: Allow the solvent to slowly dissolve the powder through gentle swirling motion. Avoid vigorous agitation or vortexing, which may compromise peptide integrity through mechanical stress.

Step 5: Continue gentle swirling until complete dissolution occurs, typically within 2-3 minutes. The solution should appear clear and colorless without visible particulates or aggregation.

Step 6: Transfer the reconstituted solution to pre-chilled, sterile low-protein-binding microcentrifuge tubes for aliquoting, minimizing repeated freeze-thaw cycles during subsequent research applications.

Concentration Reference Table

Solvent Volume Final Concentration Per 10μL Aliquot
1.0 mL 1.0 mg/mL 10 μg
2.0 mL 0.5 mg/mL 5 μg
5.0 mL 0.2 mg/mL 2 μg

Storage Conditions and Stability

Store reconstituted IGF-1 LR3 solutions at +2°C to +8°C for short-term applications up to 7 days. For extended storage periods, maintain aliquoted samples at -20°C to preserve peptide stability for up to 3 months. Avoid repeated freeze-thaw cycles, which may result in peptide aggregation and reduced biological activity.

Protect stored solutions from direct light exposure and maintain consistent temperature conditions. Label all storage containers with reconstitution date, concentration, and storage temperature requirements for proper laboratory inventory management.

Research Application Notes

Element SARMs recommends conducting preliminary dose-response studies to establish optimal working concentrations for specific cell culture applications. Consider the enhanced potency of IGF-1 LR3 compared to native IGF-1 when designing experimental protocols. Typical working concentrations in cell culture systems range from 10-100 ng/mL, requiring appropriate dilution from stock solutions.

Maintain sterile technique throughout all handling procedures and document reconstitution parameters for reproducible experimental conditions. This reconstitution protocol ensures optimal peptide stability and research reliability for in vitro applications.

All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.